Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × tipifarnib × Clear all

NCT00054470 2012-06-29

Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male